Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials. [electronic resource]
Producer: 20140811Description: 149-54 p. digitalISSN:- 1569-8041
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bevacizumab
- Brain Neoplasms -- drug therapy
- Carcinoma, Renal Cell -- drug therapy
- Clinical Trials as Topic
- Disease-Free Survival
- Eligibility Determination
- Humans
- Indazoles
- Indoles -- administration & dosage
- Kaplan-Meier Estimate
- Karnofsky Performance Status
- Kidney Neoplasms -- drug therapy
- Middle Aged
- Molecular Targeted Therapy
- Niacinamide -- administration & dosage
- Phenylurea Compounds -- administration & dosage
- Pyrimidines -- administration & dosage
- Pyrroles -- administration & dosage
- Sorafenib
- Sulfonamides -- administration & dosage
- Sunitinib
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.